Skip to main content
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
Carlos E. Araujo
Sign up to set email alerts
20
Publications
117
Citation Statements Received
41
Citation Statements Given
How they've been cited
303
2
113
2
How they cite others
264
5
36
0
Affiliations
Pulmonary and Critical Care Associates
,
Instituto de Oncología de Rosario
Publications
Order By: Most citations
Dosing and side-effects of ifosfamide plus mesna
Brade
1
,
Herdrich
2
,
Kachel-Fischer
3
et al.
1991
J Cancer Res Clin Oncol
Abstract
Show
36
0
29
1
Get access via publisher
Add to collection
Cite
Tumor Regression of Advanced Carcinomas Following Intra-and/or Peri-Tumoral Inoculation with VRCTC-310 in Humans: Preliminary Report of Two Cases
Costa
1
,
Miles
2
,
Araujo
3
et al.
1998
Immunopharmacology and Immunotoxicology
40
0
17
0
Get access via publisher
Add to collection
Cite
Impact of CD34 Cell Dose and Conditioning Regimen on Outcomes after Haploidentical Donor Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for Relapsed/Refractory Severe Aplastic Anemia
Arcuri
1
,
Nabhan
2
,
Cunha
3
et al.
2020
Biology of Blood and Marrow Transplantation
51
0
18
0
Get access via publisher
Add to collection
Cite
Phase I study of VRCTC-310, a purified phospholipase A2 purified from snake venom, in patients with refractory cancer: safety and pharmacokinetic data
Costa
1
,
Miles
2
,
Díez
3
et al.
1997
Anti-Cancer Drugs
27
0
15
0
Get access via publisher
Add to collection
Cite
Ifosfamide and mesna at high doses for the treatment of cancer of the cervix: a GETLAC study
Cervellino
1
,
Araujo
2
,
Pirisi
3
et al.
1990
Cancer Chemother. Pharmacol.
Abstract
Show
25
0
9
0
Get access via publisher
Add to collection
Cite
Cisplatin and Ifosfamide in Patients with Advanced Squamous Cell Carcinoma of the Uterine Cervix A phase II trial
Cervellino
1
,
Araujo
2
,
Sánchez
3
et al.
1995
Acta Oncologica
Abstract
Show
24
0
7
0
Get access via publisher
Add to collection
Cite
Treatment of Non-Small Cell Lung Cancer with Ifosfamide (IFO) + 4’-Epiadriamycin (EPI) + Platinum vs. IFO + EPI: A GETLAC Study
Brocato
1
,
Bruno
2
,
Araujo
3
et al.
2009
Oncology
Abstract
Show
13
0
5
1
Get access via publisher
Add to collection
Cite
Chemotherapy with high dose ifosfamide/mesna plus cisplatin for the treatment of ovarian cancer: A study of the Grupo de Estudio y Tratamiento Latino‐Americano del cancer
Araujo
1
,
Cervellino
2
,
Pirisi
3
et al.
1991
Journal of Surgical Oncology
Abstract
Show
8
2
4
0
Get access via publisher
Add to collection
Cite
1
2
3